Strong transthyretin immunostaining: Potential pitfall in cardiac amyloid typing

American Journal of Surgical Pathology

Volumn 35, Issue 11, 2011, Pages 1685-1690

  Satoskar, Anjali A ^a   Efebera, Yvonne ^b   Hasan, Ayesha ^c   Brodsky, Sergey ^a   Nadasdy, Gyongyi ^a   Dogan, Ahmet ^d   Nadasdy, Tibor ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b Department of Hemato Oncology ^*  (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

Author keywords

cardiac amyloid; immunohistochemistry; transthyretin

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; PREALBUMIN; SERUM AMYLOID A;

AGED; AMYLOIDOSIS; ARTICLE; BIOPSY; CARDIOMYOPATHY; CHEMISTRY; FEMALE; HEART MUSCLE; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; LIQUID CHROMATOGRAPHY; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PARAPROTEINEMIA; PREDICTIVE VALUE; PROGNOSIS; PROTEOMICS; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY;

AGED; AGED, 80 AND OVER; AMYLOIDOSIS; BIOPSY; CARDIOMYOPATHIES; CHROMATOGRAPHY, LIQUID; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYOCARDIUM; PARAPROTEINEMIAS; PREALBUMIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SERUM AMYLOID A PROTEIN; TANDEM MASS SPECTROMETRY;

EID: 80054995001     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182263d74     Document Type: Article

References (17)

1. Chee CE, Lacy MQ, Dogan A, et al. Pitfalls in the diagnosis of primary amyloidosis: review. Clin Lymphoma Myeloma Leuk. 2010; 10:177-180.
2. Eshaghian S, Kaul S, Shah PK. Cardiac amyloidosis: new insights into diagnosis and management. Rev Cardiovasc Med. 2007;8:189-199.
3. Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005;112:2047-2060. (Pubitemid 41377426)
4. Hassan W, Al-Sergani H, Mourad W, et al. Amyloid heart disease: new frontiers and insights in pathophysiology, diagnosis and management. Tex Heart Inst J. 2005;32:178-184. (Pubitemid 40800126)
5. Hoyer C, Angermann CE, Knop S, et al. Cardiac amyloidosis. Med Klin (Munich). 2008;103:153-160. (Pubitemid 351437835)
6. Ikeda S. Cardiac amyloidosis: heterogeneous pathogenic backgrounds. Intern Med. 2004;43:1107-1114. (Pubitemid 40074144)
7. Kieninger B, Eriksson M, Kandolf R, et al. Amyloid in endomyocardial biopsies. Virchows Arch. 2010;456:523-532.
8. Kyle RA, Spittell PC, Gertz MA, et al. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med. 1996;101:395-400. (Pubitemid 26392857)
9. Lachmann HJ, Booth DR, Booth SE, et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med. 2002;346:1786-1791. (Pubitemid 34586914)
10. Murphy CL, Wang S, Williams T, et al. Characterization of systemic amyloid deposits by mass spectrometry. Methods Enzymol. 2006;412:48-62. (Pubitemid 44548573)
11. Novak L, Cook WJ, Herrera GA, et al. AL-amyloidosis is underdiagnosed in renal biopsies. Nephrol Dial Transplant. 2004;19:3050-3053. (Pubitemid 40057627)
12. Picken MM. New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens. 2007;16: 196-203. (Pubitemid 46608527)
13. Rö cken C, Schwotzer EB, Linke RP, et al. The classification of amyloid deposits in clinicopathological practice. Histopathology. 1996;29:325-335. (Pubitemid 26338436)
14. Rö chen C, Sletten K. Amyloid in surgical pathology. Virchows Arch. 2003;443:3-16. (Pubitemid 36920945)
15. Saraiva MJM. Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies. Expert reviews in molecular medicine. 2002. www.expertreviews.org/02004647 h.htm.
16. Satoskar AA, Burdge K, Cowden DJ, et al. Typing of amyloidosis in renal biopsies: diagnostic pitfalls. Arch Pathol Lab Med. 2007;131: 917-922. (Pubitemid 46906383)
17. Vrana JA, Gamez JD, Madden BJ, et al. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009;114: 4957-4959.